🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

#HCPs #AscendisPharma is looking forward to this year’s American Thyroid Association annual meeting on September 27 – October 1 in Washington, DC.

#HCPs #AscendisPharma is looking forward to presenting our data on post-surgical hypoparathyroidism patients at this year’s American Thyroid Association annual meeting.

#HCPs #AscendisPharma is looking forward to #ASBMR2023, the American Society for Bone and Mineral Research annual meeting in Vancouver, Canada on Oct. 13-16. Visit us at booth #1117. ASBMR

#AscendisPharma is looking forward to attending the @NORD Breakthrough Summit in Washington, DC from Oct. 16-17 to support patient advocates dedicated to helping individuals with #RareDiseases.

#HCPs Today, Dr. Aliya Khan will present new skeletal dynamics data from the #AscendisPharma PaTHway clinical trial in Adult #Hypoparathyroidism the ASBMR annual meeting in Vancouver, Canada. #ASBMR2023

At this year’s AMCP #Nexus2023 annual meeting in Orlando, FL, #AscendisPharma will share poster presentations in Adult #Hypoparathyroidism and Pediatric #GrowthHormoneDeficiency.

#HCPs This year is the 56th annual scientific meeting of the Japanese Society for Pediatric Endocrinology in Saitama, Japan. #AscendisPharma is looking forward to attending and interacting with attendees there on Oct. 19-21.

#HCPs #AscendisPharma team members are joining international colleagues at #ESMO23, the European Society for Medical Oncology congress on Oct. 20-24 in Madrid, Spain. Visit us at booth #551. ESMO - Eur. Oncology

#HCPs #AscendisPharma to share new data from our IL-2 b/g program at #ESMO23, the European Society for Medical Oncology in Madrid, Spain. ESMO - Eur. Oncology

#HCPs The #AscendisPharma medical team will be at JA-PED 2023, the German Pediatric Endocrine Society annual meeting in Ulm, Germany on November 2-4. Come visit us at booth #4.

During #NationalFamilyCaregiversMonth, #AscendisPharma recognizes the amazing work of caregivers everywhere. #CaregiversConnect #FamilyCaregivers

#AscendisPharma is at #SITC23, the Society for Immunotherapy of Cancer in San Diego, CA from Nov 1-5. Visit our booth to learn more about our work in immunotherapy. Society for Immunotherapy of Cancer

#HCPs #AscendisPharma is attending #ASN2023, the American Society of Nephrology annual meeting during #KidneyWeek on November 2-5 in Philadelphia, PA.

The #AscendisPharma team will be at the HypoPARA Association 2023 International #HypoPARAthyroidism Conference. We look forward to connecting with the #hypopara community and hearing from experts about the latest on this #raredisease.

#HCPs #AscendisPharma to share results from its Phase 3 enliGHten open-label extension trial in pediatric #GrowthHormoneDeficiency at the German Pediatric Endocrine Society annual meeting.

#AscendisPharma is looking forward to attending this year’s #ISPOREurope annual conference in Copenhagen, Denmark from November 12-15.

#HCPs The #AscendisPharma German team is looking forward to attending the 41st Annual Meeting of the CAEK, Chirurgische Arbeitsgemeinschaft Endokrinologie, taking place in Vienna, Austria from November 23-25.

From all of us at #AscendisPharma, we wish you the very best this holiday season. We look forward to a new year of collaboration and innovation as we work together to make a meaningful difference in the lives of patients.

#PRESS #AscendisPharma announces our Q2 2024 results and provides a business update. Learn more on the Investors & News section of our website.

#PRESS #AscendisPharma announces topline results from its pivotal ApproaCH Trial of TransCon CNP in children with #achondroplasia. Learn more: investors.ascendispharma.com